This inventor holds 1 USPTO granted patent and 4 published patent applications. Top assignee: University of Utah Research Foundation. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: David Krizaj and TRPV4 Receptor Ligands.
Introduction
David Krizaj is an inventor associated with Salt Lake City, Utah, and the University of Utah Research Foundation. His work includes research on TRPV4 receptor ligands and their potential applications in treating ocular disorders.
Latest Patents
Krizaj is named on 1 patent, titled “TRPV4 Receptor Ligands.” The patent describes ligands of transient receptor potential cation channel subfamily V member 4 (TRPV4), pharmaceutical compositions containing these compounds, and methods for using them to treat ocular disorders.
Career Highlights
The patent reflects work connecting receptor biology with potential pharmaceutical approaches to eye conditions. The University of Utah Research Foundation is identified as the organization associated with the invention.
Collaborations
Krizaj’s listed coworkers include Paul R. Sebahar and Seth Grant. Their names are associated with the collaborative research and patent context provided.
Conclusion
David Krizaj’s patent on TRPV4 receptor ligands highlights research into compounds and compositions that may support new approaches to treating ocular disorders.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile